Skip to main content
. 2017 Apr 11;65(3):486–494. doi: 10.1093/cid/cix336

Figure 4.

Figure 4.

Summary of results of trials comparing AL to non-ACTs for gametocyte clearance at post-treatment day 14. High statistical heterogeneity (I2 = 0.75) precluded meta-analysis of these trials. Abbreviations: ACT, artemisinin-based combination therapy; AL, artemether-lumefantrine; CI, confidence interval; M-H, Mantel-Haenszel.